Roth Capital Maintains Buy on Joint, Raises Price Target to $100
Roth Capital analyst George Kelly maintains Joint (NASDAQ:JYNT) with a Buy and raises the price target from $65 to $100.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 255 companies made new 52-week highs.
The Joint Corp. Reports Will Open First Clinic In Michigan
The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, today announced the opening of its first clinic in the state of Michigan. The Joint
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 216 companies hit new 52-week highs.
Maxim Group Downgrades Joint to Hold
Maxim Group analyst Anthony Vendetti downgrades Joint (NASDAQ:JYNT) from Buy to Hold.
54 Biggest Movers From Yesterday
Gainers
Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.